Phase 4 Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People scheduled for a hysteroscopic myomectomy (a procedure to remove fibroids through the cervix) for uterine fibroids that have been confirmed by a pelvic ultrasound or MRI scan within the last 12 months
- People aged 18 to 50 years old
- People whose fibroids are between 1 and 3 centimetres in size
- People whose procedure will use one of two specific surgical tools called a Myosure or a resectoscope
- People who are willing to receive either a medication called misoprostol or a placebo (inactive substitute) via the rectum during the procedure
- People who are able to understand and are willing to sign a written consent form to participate
- People with a medical and surgical history that the trial team considers acceptable (confirm with trial site)
- People who have previously been treated with certain hormonal medications, including Depo-Lupron, Depo-Provera, or the oral contraceptive pill
- People who have previously had a Caesarean section delivery
Who may not be able to join:
- People who are currently pregnant, or who do not return a negative pregnancy test before the procedure
- People who have gone through menopause
- People with a history of gynaecological cancer
- People who have had an allergic reaction to misoprostol or medications with a similar chemical or biological makeup
- People with serious uncontrolled health conditions, such as an active infection, heart failure, unstable chest pain, irregular heart rhythms, or a psychiatric or personal situation that may make it difficult to follow the study requirements
- People with a known active inflammatory bowel condition affecting the rectum, or other significant rectal or anal conditions that could make it unsafe to receive medication via the rectum
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Magy Milad, MD, Northwestern University Feinberg School of Medicine, Northwestern Department of Obstetrics and Gynecology, Division of Minimally Invasive Gyn Surgery
Phone: 3126946773
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Fluid Deficit
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.